These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients. Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296 [No Abstract] [Full Text] [Related]
9. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
10. Dialysis and transplant patients in the long term. Bonomini V; Scolari MP; Stefoni S; Vangelista A Ann Ital Med Int; 1993; 8(2):73-9. PubMed ID: 8353022 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance. Moss AH; Solomons CC; Alfrey AC Proc Clin Dial Transplant Forum; 1979; 9():184-8. PubMed ID: 399505 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation]. Krzanowski M; Stompór T; Kuśnierz-Cabala B; Ignacak E; Sułowicz W; Naskalski JW Przegl Lek; 2006; 63(8):597-601. PubMed ID: 17441364 [TBL] [Abstract][Full Text] [Related]
13. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891 [TBL] [Abstract][Full Text] [Related]
14. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology. Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370 [No Abstract] [Full Text] [Related]
15. [Serum copper and manganese serum concentrations in uremia]. Börner H; Mehnert E; Bruhn P; Hudec R Z Urol Nephrol; 1983 Aug; 76(8):544-8. PubMed ID: 6356702 [No Abstract] [Full Text] [Related]
16. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Vamvakas S; Bahner U; Becker P; Steinle A; Götz R; Heidland A Transplant Proc; 1996 Dec; 28(6):3468-73. PubMed ID: 8962350 [No Abstract] [Full Text] [Related]
17. Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list. Roberts MA; MacMillan N; Hare DL; Ratnaike S; Sikaris K; Fraenkel MB; Ierino FL Nephrology (Carlton); 2006 Oct; 11(5):471-6. PubMed ID: 17014564 [TBL] [Abstract][Full Text] [Related]
18. Suppression of interferon response in lymphocytes from patients with uremia. Sanders CV; Luby JP; Sanford JP; Hull AR J Lab Clin Med; 1971 May; 77(5):768-76. PubMed ID: 5557663 [No Abstract] [Full Text] [Related]
19. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients. Möhring K; Pomer S; Daniel U; Rambausek M Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470 [No Abstract] [Full Text] [Related]
20. Selenium concentrations and glutathione peroxidase activities in blood of patients before and after allogenic kidney transplantation. Zachara BA; Włodarczyk Z; Masztalerz M; Adamowicz A; Gromadzinska J; Wasowicz W Biol Trace Elem Res; 2004 Jan; 97(1):1-13. PubMed ID: 14742896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]